MedPath

The effect of suprainguinal fascia iliaca compartment block

Phase 1
Conditions
Hip Pain
Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Registration Number
CTIS2023-510388-37-00
Lead Sponsor
Region Midtjylland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

American Society of Anesthesiologists physical status classification score (ASA) I-II, Age = 18 years, BMI < 25 kg/m², Able to read and understand Danish as well as read, understand and sign informed written consent, Weight = 69 kg

Exclusion Criteria

Inability to cooperate, Decreased sense of touch on the lower extremities assessed by examination by the investigator before the start of the trial, Known coagulopathy, Infection in the areas of insertion sites for nerve blocks and EMG examination, Allergy to local analgesics used in the study (Ropivacaine), Allergy to contrast agents for MR scanning (Gadoteric acid), Daily medication consumption besides oral contraception, Abuse of alcohol, drugs or medication, Pregnancy, Unable to speak and understand Danish, Fear of needles, Claustrophobia, Metallic implants in the body incl. pacemaker, Known reduced kidney function, Known reduced liver function, Previously operated on in the hip area or groin, Known neuropathy in the lower extremities

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath